Non-ATP competitive protein kinase inhibitors

Area of Science:

• Oncology Drug Discovery
• Medicinal Chemistry
• Structural Biology

Background:

• Protein kinases are key targets in cancer therapy.
• ATP-competitive (Type I) inhibitors face challenges with selectivity and cellular activity due to conserved ATP-binding pockets and high intracellular ATP levels.
• Non-ATP-competitive inhibitors (Type II and III) offer potential solutions by inducing conformational changes.

Purpose of the Study:

• To review small molecules that induce the DFG-out kinase conformation.
• To focus on the structural features, structure-activity relationships (SAR), and biological properties of these inhibitors.

Main Methods:

• Literature review of non-ATP-competitive kinase inhibitors.
• Analysis of structural characteristics, including hinge-binding moieties, hydrophobic pockets, and allosteric site interactions.
• Examination of structure-activity relationships (SAR) and biological data.

Main Results:

• Non-ATP-competitive inhibitors induce a DFG-out conformation, creating an allosteric pocket.
• These inhibitors typically feature a heterocyclic system for hinge binding and a hydrophobic moiety for the allosteric pocket.
• A linker, often urea or amide, connects these features and interacts with the allosteric site.

Conclusions:

• Non-ATP-competitive inhibitors represent a promising strategy for developing selective and effective kinase-targeted cancer therapies.
• Understanding the structural requirements for DFG-out induction is crucial for rational drug design.
• These inhibitors can overcome limitations associated with ATP-competitive agents.